Summary by Futu AI
SHANGHAI FUSTAR PHARMACEUTICALS (GROUP) CO., LTD. (“FUSTAR PHARMACEUTICALS”) ANNOUNCES TWO PARALLEL FUNDS JOINTLY ESTABLISHED BY ITS HOLDING SUBSIDIARY/ENTERPRISE SHANGHAI FUYU SHENGJIAN ENTERPRISE MANAGEMENT PARTNERSHIP (LIMITED PARTNERSHIP) AND NINGBO FUYING INVESTMENT CO., LTD. WITH OTHER INVESTORS — ANJI FUXING The Startup Investment Partnership (Limited Partnership) and Xuzhou Fuyu Pengtai Venture Investment Partnership (Limited Partnership) have recently completed their filing with the Securities Investment Fund Industry Association of China. The two funds will hire Shanghai Rehabilitation Equity Investment Fund Management Co., Ltd., a subsidiary of Resusstar Pharmaceutical Holdings, as fund managers and will jointly implement foreign investments under the conditions agreed in their respective decision-making mechanisms. The news was announced by the Board of Directors of Fustar Pharmaceuticals on April 22, 2024.